Vanberra Signal

NeuroLex Diagnostics

Curated by Signal

Speech based tool to screen for psychotic and neurological disorders

Overview

NeuroLex Diagnostics is developing a tool for physicians to screen the patient for psychotic and neurological disorders with a focus on Depression, Schizophrenia, Parkinson’s Disease, and Alzheimer’s Disease. It analyses speech samples using machine learning to detect health abnormalities. Patients and providers can use the tool to analyze patient health. Their offering also includes DepLex assay, AlzLex assay to detect AD symptoms early and characterize memory decline as AD progress, and others.

Key facts

Founded
2016

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of cannabis-based products for health and wellness

    Health TechnologyMiami, United States
  • Online resource that provides health and nutrition information

    Health TechnologyScottsdale, United States
  • Provider of a nutrition tracking app for the consumers

    Health TechnologyLexington Park, United States

About NeuroLex Diagnostics

What does NeuroLex Diagnostics do?

NeuroLex Diagnostics is developing a tool for physicians to screen the patient for psychotic and neurological disorders with a focus on Depression, Schizophrenia, Parkinson’s Disease, and Alzheimer’s Disease.

Where is NeuroLex Diagnostics headquartered?

NeuroLex Diagnostics is headquartered in Atlanta, United States.

When was NeuroLex Diagnostics founded?

NeuroLex Diagnostics was founded in 2016.

Which sector is NeuroLex Diagnostics in?

NeuroLex Diagnostics operates in Health Technology.

Who are NeuroLex Diagnostics's competitors?

Companies similar to NeuroLex Diagnostics include NOVU, Dieticians, and Healthy Nutrition Tracker.